OptimizeRx Corporation, a digital health technology company, engages in the provision of tech-enabled marketing solutions for life sciences organizations, healthcare providers, and patients. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.

OptimizeRx Corporation

In a report released on November 14, David Grossman from Stifel Nicolaus maintained a Buy rating on OptimizeRx, with a price target of $24.83. Acco...

Stifel Nicolaus Remains a Buy on OptimizeRx (OPRX)

Stifel Nicolaus analyst David Grossman maintained a Buy rating on OptimizeRx today and set a price target of $21.00. According to TipRanks, Grossma...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	OPRX	$14.59	+7.44%	258.22K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	OPRX	$14.59	+7.4%	258.22K
3
4
5
6

OPRX

OPRX

Latest News for OPRX

Get OptimizeRx Corporation Data in Excel

Get OptimizeRx Corporation Data in Excel